NADPH-dependent oxidation of benzidine by rat liver

Carcinogenesis

Volumn 17, Issue 9, 1996, Pages 1941-1947

  Lakshmi, Vijaya M ^a   Zenser, Nathan T ^a   Hsu, F F ^b   Mattammal, Michael B ^a   Zenser, Terry V ^a,c   Davis, Bernard B ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BENZIDINE; BENZIDINE DERIVATIVE; BETA NAPHTHOFLAVONE; CYTOCHROME P450; DRUG METABOLITE; ELLIPTICINE; ENZYME INHIBITOR; GLUTATHIONE; N ACETYLMETHIONINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL CELL; ARTICLE; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DNA BINDING; DRUG METABOLISM; DRUG OXIDATION; DRUG PROTEIN BINDING; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER METABOLISM; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029789580     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.9.1941     Document Type: Article

References (50)

1. Case, R.A.M., Hosker, M.W., McDonald, D.B. and Pearson, J.T. (1954) Tumors of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Br. J. Indust. Med., 11, 75-104.
2. Zavon, M.R., Hoegg, U. and Bingham, E. (1973) Benzidine exposure as a cause of bladder tumors. Arch. Environ. Health, 27, 1-7.
3. Bi, W. et al. (1992) Mortality and incidence of bladder cancer in benzidine-exposed workers in China. Am. J. Indust. Med., 21, 481-489.
4. Schulte, P.A., Ward, E., Boeniger, M. and Hills, B. (1988) Occupational exposure to N-substituted aryl compounds. In King, C.M., Romano, L.J. and Schuetzle, D. (eds), Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes. Elsevier Science, New York, NY, pp. 23-35.
5. Deguchi, T., Mashimo, M. and and Suzuki, T. (1990) Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J. Biol. Chem., 265, 12757-12760.
6. Blum, M., Demierre, A., Grant, D.M., Heim, M. and Meyer, U.A. (1991) Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. Natl Acad. Sci. USA, 88, 5237-5241.
7. Weber, W.W. and Hein, D.W. (1985) N-Acetylation pharmacogenetics. Pharmacol. Rev., 37, 25-79.
8. Hein, D.W. (1988) Acetylator genotype and arylamine-induced carcinogenesis. Biochim. Biophys. Acta, 948, 37-66.
9. Grant, D.M., Josephy, P.D., Lord, H.L. and Morrison, L.D. (1992) Salmonella typhimurium strains expressing human arylamine N-acetyltransferases: metabolism and mutagenic activation of aromatic amines. Cancer Res., 52, 3961-3964.
10. Sciarini, L.J. and Meigs, J.W. (1961) The biotransformation of benzidine. II. Studies in mouse and man. Arch. Environ. Health, 2, 423-428.
11. Dewan, A., Jani, J.P., Patel, J.S., Gandhi, D.N., Variya, M.R. and Ghodasara, N.B. (1988) Benzidine and its acetylated metabolites in the urine of workers exposed to Direct Black 38. Arch. Environ. Health, 43, 269-272.
12. Hsu, F., Lakshmi, V., Rothman, N. et al. (1996) Determination of benzidine, N-acetylbenzidine and N,N′-diacetylbenzidine in human urine by capillary gas chromatography/negative ion chemical ionization mass spectrometry. Anal. Biochem., 234, 183-189.
13. Lynn, R.K., Garvie-Gould, C., Milam, D.F., Scott, K.F., Eastman, C.L. and Rodgers, R.M. (1983) Metabolism of the human carcinogen, benzidine, in the isolated perfused rat liver. Drug Metab. Dispos., 11, 109-114.
14. Lynn, R.K., Garvie-Gould, C.T., Milam, D.F., Scott, K.F., Eastman, C.L., Ilias, A.M. and Rodgers, R.M. (1984) Disposition of the aromatic amine, benzidine, in the rat: characterization of mutagenic urinary and biliary metabolites. Toxicol. Appl. Pharmacol., 72, 1-14.
15. Lakshmi, V.M., Bell, D.A., Watson, M.A., Zenser, T.V. and Davis, B.B. (1995) N-Acetylbenzidine and N,N′-diacetylbenzidine formation by rat and human liver slices exposed to benzidine. Carcinogenesis, 16, 1565-1571.
16. Frederick, C.B., Weis, C.C., Flammang, T.J., Martin, C.N. and Kadlubar, F.F. (1985) Hepatic N-oxidation, acetyl-transfer and DNA-binding of the acetylated metabolites of the carcinogen, benzidine. Carcinogenesis, 6, 959-965.
17. Zenser, T.V., Mattammal, M.B. and Davis, B.B. (1979) Cooxidation of benzidine by renal medullary prostaglandin cyclooxygenase. J. Pharmacol. Exp. Ther., 211, 460-464.
18. Poulsen, L.L., Taylor, K., Williams, D.E., Siler-Masters, B.S. and Ziegler, D.M. (1986) Substrate specificity of the rabbit lung flavin-containing monooxygenase for amines: oxidation products of primary alkylamines. Mol. Pharmacol., 30, 680-685.
19. Butler, M.A., Guengerich, F.P. and Kadlubar, F.F. (1989) Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Cancer Res., 49, 25-31.
20. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl Acad. Sci. USA, 86, 7696-7700.
21. Orzechowski, A., Schrenk, D., Schut, H.A.J. and Bock, K.W. (1994) Consequences of 3-methylcholanthrene-type induction for the metabolism of 4-aminobiphenyl in isolated rat hepatocytes. Carcinogenesis, 15, 489-494.
22. Guengerich, F.P., Wang, P. and Davidson, N.K. (1995) Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry, 21, 1698-1706.
23. Zenser, T.V., Mattammal, M.B. and Davis, B.B. (1978) Differential distribution of the mixed-function oxidase activities in rabbit kidney. J. Pharmacol. Exp. Ther., 207, 719-725.
24. Gupta, R.C., Earley, K. and Sharma, S. (1988) Use of human peripheral blood lymphocytes to measure DNA binding capacity of chemical carcinogens. Proc. Natl Acad. Sci. USA, 85, 3513-3517.
25. 32P-Postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis (Lond.), 3, 1081-1092.
26. 32P-postlabeling analysis of aromatic carcinogen-DNA adducts. Cancer Res., 45, 5656-5662.
27. Wise, R.W., Zenser, T.V. and Davis, B.B. (1984) Characterization of benzidinediimine: a product of peroxidase metabolism of benzidine. Carcinogenesis, 5, 1499-1503.
28. Yamazoe, Y., Roth, R.W. and Kadlubar, F.F. (1986) Reactivity of benzidine diimine with DNA to form N-(deoxyguanosin-8-yl)-benzidine. Carcinogenesis, 7, 179-182.
29. Lakshmi, V.M., Zenser, T.V., Goldman, H.D., Spencer, G.G., Gupta, R.C., Hsu, F.F. and Davis, B.B. (1995) The role of acetylation in benzidine metabolism and DNA adduct formation in dog and rat liver. Chem. Res. Toxicol., 8, 711-720.
30. Sciarini, L. (1957) 3-Hydroxybenzidine, a metabolite of benzidine. Arch. Biochem. Biophys., 71, 437-441.
31. Bhatt, M.V. and Kulkarani, S.U. (1983) Cleavage of ethers. Synthesis, 249-282.
32. Wise, R.W., Zenser, T.V. and Davis, B.B. (1985) Prostaglandin H synthase oxidation of benzidine and o-dianisidine: reduction and conjugation of activated amines by thiols. Carcinogenesis, 6, 579-583.
33. Budzikiewicz, H., Djerassi, C. and Williams, D.H. (1967) Mass Spectrometry of Organic Compounds. Holden-Day Inc., San Francisco, CA, pp. 322-327.
34. Wise, R.W., Zenser, T.V., Kadlubar, F.F. and Davis, B.B. (1984) Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. Cancer Res., 44, 1893-1897.
35. Lakshmi, V.M., Mattammal, M.B., Zenser, T.V. and Davis, B.B. (1990) Mechanism of peroxidative activation of the bladder carcinogen 2-amino-4-(5-nitro-2-furyl)-thiazole (ANFT): comparison with benzidine. Carcinogenesis, 11, 1965-1970.
36. Yamazoe, Y., Zenser, T.V., Miller, D.W. and Kadlubar, F.F. (1988) Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine. Carcinogenesis, 9, 1635-1641.
37. Lakshmi, V.M., Zenser, T.V. and Davis, B.B. (1994) Mechanism of 3-(glutathion-S-yl)-benzidine formation. Toxicol. Appl. Pharmacol., 125, 256-263.
38. Wise, R.W., Zenser, T.V. and Davis, B.B. (1983) Prostaglandin H synthase metabolism of the urinary bladder carcinogens benzidine and ANFT. Carcinogenesis, 4, 285-289.
39. Boteju, L.W. and Hanna, P.E. (1993) Bioactivation of N-hydroxy-2-acetylaminofluorenes by N,O-acyltransferase: substituent effects on covalent binding to DNA. Carcinogenesis, 14, 1651-1657.
40. Bartsch, H., Dworkin, M., Miller, J.A. and Miller, E.C. (1972) Electrophilic N-acetoxyaminoarenes derived from carcinogenic N-hydroxy-N-acetylaminoarenes by enzymatic deacetylation and transacetylation in liver. Biochim. Biophys. Acta, 286, 272-298.
41. Elfarra, A.A. and Hanna, P.E. (1985) Substituent effects on the bioactivation of 2-(N-hydroxyacetamido)fluorenes by N-arylhydroxamic acid N,O-acyltransferase. J. Med. Chem., 28, 1453-1460.
42. Lakshmi, V.M., Mattammal, M.B., Spry, L.A., Kadlubar, F.F., Zenser, T.V. and Davis, B.B. (1990) Metabolism and disposition of benzidine in the dog. Carcinogenesis, 11, 139-144.
43. Troll, W. and Nelson, N. (1958) Studies on aromatic amines. I. Preliminary observations on benzidine metabolism. Indust. Hygiene J., 19, 499-503.
44. Rothman, N., Bhatnagar, V.K., Hayes, R.B. et al. (1996) The impact of NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. Proc. Natl Acad. Sci. USA, 93, 5084-5089.
45. Hammons, G.J., Guengerich, F.P., Weis, C.C., Beland, F.A. and Kadlubar, F.F. (1985) Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases. Cancer Res., 45, 3578-3585.
46. Kadlubar, F.F., Frederick, C.B., Weis, C.C. and Zenser, T.V. (1982) Prostaglandin endoperoxide synthetase-mediated metabolism of carcinogenic aromatic amines and their binding to DNA and protein. Biochem. Biophys. Res. Commun., 108, 253-258.
47. Zenser, T.V., Mattammal, M.B., Armbrecht, H.J. and Davis, B.B. (1980) Benzidine binding to nucleic acids mediated by the peroxidative activity of prostaglandin endoperoxide synthetase. Cancer Res., 40, 2839-2845.
48. Danon, A., Zenser, T.V., Thomasson, D.L. and Davis, B.B. (1986) Eicosanoid synthesis by cultured human urothelial cells: potential role in bladder cancer. Cancer Res., 46, 5676-5681.
49. Flammang, T.J., Yamazoe, Y., Benson, R.W., Roberts, D.W., Potter, D.W., Chu, D.Z.J., Lang, N.P. and Kadlubar, F.F. (1989) Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes. Cancer Res., 49, 1977-1982.
50. Yamazoe, Y., Miller, D.W., Weis, C.C., Dooley, K.L., Zenser, T.V., Beland, F.A. and Kadlubar, F.F. (1985) DNA adducts formed by ring-oxidation of the carcinogen 2-naphthylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo. Carcinogenesis, 6, 1379-1387.